Wall Street unfazed by FDA panel’s rejection of company’s wireless heart monitoring device.
|
Startup InnerPulse grabs the funding from venture capital and med-tech companies for implant to help folks survive sudden cardiac arrest.
|
The med-tech giant’s shares tick upward as defibrillator market stabilizes.
|
Investors look to get insight on the medical device industry’s coming year with top chief Art Collins.
|
Year in Review: Innovation and controversy defined the medical technology industry.
|
Study shows implantable device helps alleviate Parkinson’s symptoms.
|
Despite slow defibrillator market, medical device maker reports results in line with lowered expectations.
|
Startup EnteroMedics grabs funding for a device to help the overweight drop the pounds.
|
The device maker pays $40 million to the U.S. government.
|
Boston Scientific shares dip 7 percent after warnings some devices could cause problems.
|
HIV test grabs U.S. approval; Medtronic’s stent OK’d in China; kicking cocaine is hard.
|
Device maker partners with Big Blue to develop system that lets doctors test and reprogram defibrillators and pacemakers.
|
A U.S. agency’s plan to cut reimbursements for heart devices dents stocks of companies that make them.
|
Firm stirs up the market with a test that could break the hearts of device makers.
|
Device maker brings next-generation diabetes management product to market.
|
An independent panel suggests how the troubled heart device maker can better its patient safety communication skills.
|
The call for less-invasive surgeries to treat orthopedic problems will drive industry’s innovation.
|
To succeed in the nascent drug-coated stent industry, startups are finding niche markets and cozying up to industry giants.
|
Boston Scientific and Guidant left Johnson & Johnson all alone by the telephone. So just who will J&J call?
|
Guidant's degraded seals; Medtronic settles suit; Neuroptix gets $500,000; outsourcing speeds drug research.
|
Page
1
of
2
|